logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • News & Events
    • Press releases
    • Events
    • Media
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Constitutional documents
    • Investor news
    • Corporate governance
    • AIM Rule 26

Shareholders

Home > Investor relations > Shareholders

Identity and percentage holding of significant shareholders
 

Substantial holdings Shares held %
Calculus Capital 6,588,032 19.4%
M&G Investment Mgt 5,178,143 15.3%
BGF Investment Management Limited 4,347,826 12.8%
Odey Asset Management 1,880,266 5.5%
River & Mercantile Asset Management 1,819,957 5.4%
 
Directors and related shareholders  
Ian Gilham 266,424 0.8%
David Budd 145,380 0.4%
Matthew Fowler 86,957 0.3%
Tom Lindsay 65,217 0.2%
Chris Yates 16,304 -
Total Directors' holdings 580,282 1.7%
     
Total shares in issue 34,000,506 100.00%

 

Shareholder information

genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.

Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.

Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 34,000,506.

Number of AIM securities not in public hands is 580,282 or 1,7%, there are no shares subject to lock-ins.

This data was updated on 2nd January 2019.

Latest reports

share price graph

12 December 2018

Annual Report and Accounts 2018

View all reports >

Investor News

Tuesday January 15, 2019

Genedrive receives second order from US Department of Defense

Thursday November 29, 2018

US giant AbbVie to fund trial of genedrive's hep C test

Thursday November 22, 2018

Genedrive 'well placed' to grow the business after £6mln equity raise

View all news >

  • Privacy
  • Terms of use
  • Site map
  • Contact us

© 2017-19 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose